Transitional QPs for investigational medicinal products (IMPs)

Posted by: , Posted on: - Categories: Compliance matters, Good clinical practice, Good manufacturing practice
QP using laptop in office

We are aware there is some concern for UK business and personal careers, over the status of transitional QPs that were recognised under the transitional arrangements provided in SI 2004/1031, when the Clinical Trials Directive was implemented in 2004. The …

The GPvP inspectorate promote compliance and best practice at 2 successful events

Posted by: , Posted on: - Categories: Compliance matters, Events and symposia, Good pharmacovigilance practice, Inside the Inspectorate
EU Inspector Training: GPvP Inspectors from the MHRA, EU and beyond and EMA staff who coordinated the event.

Late last year the GPvP inspectorate ran its own symposium and contributed heavily to the EU pharmacovigilance inspector training event. GPvP symposium The GPvP inspectorate held a sell-out symposium in London in November attended by approximately 350 delegates. GPvP inspectors highlighted requirements, …